Steven E. Lufkin
Amministratore Delegato presso SeLux Diagnostics, Inc.
Posizioni attive di Steven E. Lufkin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
SeLux Diagnostics, Inc.
 SeLux Diagnostics, Inc. Medical SpecialtiesHealth Technology SeLux Diagnostics, Inc. develops universal synthetic amplifier technology equipment. The firm offers Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. The company was founded by Eric Stern and Aleksander Vacic in 2014 and is headquartered in Charlestown, MA. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | 01/01/2017 | - |
Storia della carriera di Steven E. Lufkin
Precedenti posizioni note di Steven E. Lufkin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ERBA DIAGNOSTICS, INC. | Corporate Officer/Principal | 27/05/2010 | 30/09/2010 |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
ERBA Diagnostics, Inc.
 ERBA Diagnostics, Inc. Medical SpecialtiesHealth Technology ERBA Diagnostics, Inc. was engaged in manufacturing and marketing of proprietary diagnostic reagents, test kits and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes, and infectious diseases. The company was founded in 1980 and was headquartered in Miami Lakes, FL. | Health Technology |
SeLux Diagnostics, Inc.
SeLux Diagnostics, Inc. Medical SpecialtiesHealth Technology SeLux Diagnostics, Inc. develops universal synthetic amplifier technology equipment. The firm offers Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. The company was founded by Eric Stern and Aleksander Vacic in 2014 and is headquartered in Charlestown, MA. | Health Technology |
- Borsa valori
- Insiders
- Steven E. Lufkin
- Esperienza
